146 related articles for article (PubMed ID: 31390899)
1. Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma.
Toxopeus E; Lynam-Lennon N; Biermann K; Dickens G; de Ruiter PE; van Lanschot J; Reynolds JV; Wijnhoven B; O'Sullivan J; van der Laan L
Exp Biol Med (Maywood); 2019 Oct; 244(14):1210-1219. PubMed ID: 31390899
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
3. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
[TBL] [Abstract][Full Text] [Related]
4. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
5. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing.
Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ
Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
Bobryshev YV; Orekhov AN; Chistiakov DA
Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
[TBL] [Abstract][Full Text] [Related]
8. MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma.
Zhao MY; Wang LM; Liu J; Huang X; Liu J; Zhang YF
Curr Med Sci; 2018 Apr; 38(2):245-251. PubMed ID: 30074182
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.
Winther M; Alsner J; Sørensen BS; Wittrup CF; Tramm T; Baeksgaard L; Hofland K; Holtved E; Nordsmark M
Anticancer Res; 2016 Feb; 36(2):721-30. PubMed ID: 26851030
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
11. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
[TBL] [Abstract][Full Text] [Related]
12. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
[TBL] [Abstract][Full Text] [Related]
13. MiR-421 expression independently predicts unfavorable overall survival in patients with esophageal adenocarcinoma.
Lin XF; Zhang CQ; Dong BR
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3790-3798. PubMed ID: 31115005
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction.
Odenthal M; Hee J; Gockel I; Sisic L; Schmitz J; Stoecklein NH; Driemel C; Möhlendick B; Schmidt T; Knoefel WT; Lang H; Büttner R; Ott K; Vallböhmer D
Int J Cancer; 2015 Jul; 137(1):230-7. PubMed ID: 25429911
[TBL] [Abstract][Full Text] [Related]
15. miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer.
Shi H; Zhou S; Liu J; Zhu J; Xue J; Gu L; Chen Y
Pathol Res Pract; 2016 May; 212(5):444-9. PubMed ID: 26944831
[TBL] [Abstract][Full Text] [Related]
16. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
Ma JB; Hu SL; Zang RK; Su Y; Liang YC; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma.
Bibby BA; Reynolds JV; Maher SG
PLoS One; 2015; 10(7):e0134180. PubMed ID: 26221725
[TBL] [Abstract][Full Text] [Related]
19. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
Chen Q; Hou J; Wu Z; Zhao J; Ma D
Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
[TBL] [Abstract][Full Text] [Related]
20. Somatic DNA Copy-Number Alterations Detection for Esophageal Adenocarcinoma Using Digital Polymerase Chain Reaction.
Lee KTW; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():195-212. PubMed ID: 29600372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
